PTO- 1581 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88858210 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 121 |
MARK SECTION | |
MARK | WELLVII (see, http://uspto.report/TM/88858210/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | WELLVII |
OWNER SECTION (current) | |
NAME | ARC Devices Ltd. |
INTERNAL ADDRESS | c/o DLI Law |
MAILING ADDRESS | 12 Merrion Square |
CITY | Dublin 2 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Ireland |
PHONE | 512-539-8753 |
XXXX | |
OWNER SECTION (proposed) | |
NAME | ARC Devices Ltd. |
INTERNAL ADDRESS | c/o DLI Law |
MAILING ADDRESS | 12 Merrion Square |
CITY | Dublin 2 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Ireland |
PHONE | 512-539-8753 |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Laura A. Genovese |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | lgenovese@kassgen.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | csmith@kassgen.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Laura A. Genovese |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | lgenovese@kassgen.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | csmith@kassgen.com |
DOCKET/REFERENCE NUMBER | VITAL.1001 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 010 |
CURRENT IDENTIFICATION | Apparatus for blood analysis; Blood glucose meter; Blood oxygen monitors; Blood pressure measuring apparatus; Blood pressure monitors; Blood pressure transducers; Blood pressure and diabetic diagnostic medical devices; Blood pretreatment apparatus and instruments; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Electronic temperature monitors for medical use; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory event; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brain, heart and metabolic functions; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of electronics for transmitting monitored data through the Internet, as a component of the medical devices; Medical instruments for measuring and displaying vital signs, blood properties and respiratory events; Medical apparatus for monitoring vital signs of patients; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Patient medical monitors for monitoring systolic blood pressure, diastolic blood pressure, blood glucose levels, blood perfusion, pulse rate, heart rate, blood oxygenation saturation (SPO2), heart rate variability, respiration rate, core body temperature, weight and electrocardiogram (ECG); Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Arterial blood pressure measuring apparatus; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 09/29/2020 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 1 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 125 |
TOTAL AMOUNT | 125 |
SIGNATURE SECTION | |
SIGNATURE | /Robert T. Faber/ |
SIGNATORY'S NAME | Robert T. Faber |
SIGNATORY'S POSITION | Chief Financial Officer |
DATE SIGNED | 02/12/2021 |
SIGNATORY'S PHONE NUMBER | xxx |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Fri Feb 12 11:48:22 ET 2021 |
TEAS STAMP | USPTO/ESU-XXXX:XXXX:XXXX: XXXX:XXXX:XXXX:XXXX:XXXX- 20210212114822304491-8885 8210-760958f26293dc04eb49 7d665f4845115111c896c5582 56e3c9a64bc13131-CC-48192 665-20210212092158744601 |
PTO- 1581 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |